Mainsail Financial Group, LLC Abb Vie Inc. Transaction History

Mainsail Financial Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $15,768 - $19,623	-119 Reduced 4.63%	2,450 $330 Million
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $94,430 - $108,750	653 Added 34.08%	2,569 $418 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $265,001 - $317,806	1,916 New	1,916 $293 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mainsail Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mainsail Financial Group, LLC with notifications on news.